http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories
-
PepGen Appoints Laurie Keating as Chair of Board of Directors
-
Quantum Genomics signs an exclusive license agreement with Teva Israel Ltd.
-
Alvotech Beats Back AbbVie’s Trade Secrets Lawsuit
-
Alvotech Provides Update on FDA Action Regarding AVT02, Proposed High-Concentration Biosimilar to Humira® (adalimumab)
-
Alvotech Announces Positive Top-Line Results for Switching Study Between Proposed Biosimilar AVT02 and Humira (TEVA)
-
Alvotech Announces Positive Top-Line Results for Switching Study Between Proposed Biosimilar AVT02 and Humira®
-
Teva and Alvotech Announce Strategic Partnership to Collaborate in the U.S. Biosimilar Market
-
Ironwood Pharma (IRWD), Allergan (AGN) Settle LINZESS (linaclotide) Patent Litigation with Teva (TEVA)
-
Several states wary of $48 billion opioid settlement proposal
-
Citi Appointed as Successor Depositary Bank for Teva’s ADR Programme
-
Express Scripts (ESRX) Announces New Value-Based Program for Migraine
-
Pre-Open Movers 09/17: (SNMX) (NBEV) (SIR) Higher; (RSLS) (PBYI) (TWTR) Lower (more...)
-
Regeneron (REGN), Teva (TEVA) Announce Positive Topline Phase 3 Fasinumab Results in Patients with Chronic Pain from OA of Knee or Hip
-
Teva and Regeneron Announce Positive Topline Phase 3 Fasinumab Results in Patients with Chronic Pain from Osteoarthritis of the Knee or Hip
-
Regeneron and Teva Announce Positive Topline Phase 3 Fasinumab Results in Patients with Chronic Pain from Osteoarthritis of the Knee or Hip
-
Pre-Open Movers 02/08: (TWTR) (INFN) (GRUB) Higher; (IRBT) (GEMP) (IPHI) Lower (more...)
-
Pre-Open Movers 01/22: (BIVV) (JUNO) (ARRY) Higher; (SANM) (TEVA) (TWTR) Lower (more...)
-
New Initiative Creates Scalable Solutions to Improve Care of Patients with Multiple Chronic Conditions
-
Teva (TEVA), Otsuka Sign Licensing Agreement for Japan on Migraine Drug Candidate Fremanezumab
-
Otsuka and Teva Sign Licensing Agreement for Japan on Prophylactic Migraine Drug Candidate Fremanezumab (TEV-48125)
-
Teva Pharma (TEVA), Regeneron (REGN) Announce FDA Clinical Hold Placed on Fasinumab Phase 2b
-
Regeneron and Teva Provide Update on Fasinumab Clinical Development Programs
-
Regeneron and Teva Provide Update on Fasinumab Clinical Development Programs
-
Regeneron (REGN), Teva Pharma (TEVA) Enter Partnership for Fasinumab Development, Commercialization
-
Teva and Regeneron Announce Global Collaboration to Develop and Commercialize Fasinumab, an Investigational NGF Antibody for Chronic Pain
-
Regeneron and Teva Announce Global Collaboration to Develop and Commercialize Fasinumab, an Investigational NGF Antibody for Chronic Pain
-
FTC: Teva (TEVA) Agrees to Divest 79 Pharma Products to Settle Actavis (AGN) Generics Merger Issues
-
Cocrystal Pharma Announces Late Breaking Abstract at AASLD Meeting (OPK) (TEVA)
-
BioTime’s Subsidiary Cell Cure Neurosciences Ltd. Receives FDA Fast-Track Designation for OpRegen® for the Treatment of the Dry Form of Age-Related Macular Degeneration
-
Top 10 News for 7/27 - 7/31: Teva Makes it Official with Allergan; China Stock Slide Continues; Revised Q2 GDP Misses Mark
-
BioTime’s Subsidiary Cell Cure Neurosciences Ltd. Awarded $1.6 Million Grant From Israel’s Office of the Chief Scientist
-
OncoGenex Regains Rights to Custirsen from Teva
-
Streetinsider.com's Hot Lunchtime Reads 4/21: (GS) (TEVA) (INO) (TWTR)
-
Trading Radar for 2/4: Twitter (TWTR), GoPro (GPRO), LinkedIn (LNKD), Kors (KORS), Philip Morris (PM) Report
-
Notable Analyst Rating Changes 04/16: (SFUN) (TWTR) (YELP) Upgraded; (INTC) (UNH) (GDP) Downgraded
-
Pre-Open Stock Movers 1/8: (PATH) (FRX) (MU) Higher; (TCS) (JCP) (TWTR) Lower (more...)
-
Unusual 11 Mid-Day Movers 12/27: (WPCS) (FREE) (ANIP) Higher; (IFON) (CLWT) (APRI) Lower
-
Pre-Open Stock Movers 12/27: (WPCS) (ANIP) (FE) Higher; (TWTR) (PTRY) (BBRY) Lower (more...)
-
Notable Analyst Rating Changes 11/04: (X) (GTI) (KSS) Upgraded; (BPI) (GPS) (AFL) Downgraded
-
Pre-Open Stock Movers 10/16: (RCPT) (AAP) (MAT) Higher; (SWK) (MCP) (JOEZ) Lower (more...)
-
Alexza's EU Partner (Grupo Ferrer) Signs New ADASUVE Deal With Medivir
-
Market Wrap: Dow Closes Below 15K; Gigamon Goes Public; 10-Year Pfizer Fight Ends